Compassionate Use

The common name for the U.S. Food and Drug Administration’s “Expanded Access” program which serves as a potential pathway for a patient with an immediately life-threatening condition or serious disease or condition to gain access to an investigational new drug product, including psychedelic drug products.

Was this helpful? Share it!